Literature DB >> 4215423

Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo.

C F Wilkinson, K Hetnarski, G P Cantwell, F J Di Carlo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4215423     DOI: 10.1016/0006-2952(74)90227-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  15 in total

Review 1.  Inhibition and induction of cytochrome P450 and the clinical implications.

Authors:  J H Lin; A Y Lu
Journal:  Clin Pharmacokinet       Date:  1998-11       Impact factor: 6.447

Review 2.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 3.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Effects of prochloraz on drug metabolism in the Japanese quail, grey partridge, chicken, and pheasant.

Authors:  J L Rivière; J Bach; G Grolleau
Journal:  Arch Environ Contam Toxicol       Date:  1985-05       Impact factor: 2.804

5.  25-Hydroxyvitamin D3-1 alpha-hydroxylase in porcine hepatic tissue: subcellular localization to both mitochondria and microsomes.

Authors:  B W Hollis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

Authors:  H S Purba; J L Maggs; M L Orme; D J Back; B K Park
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

7.  Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D.

Authors:  Jon G Mabley; Rebecca Wallace; Pál Pacher; Kanneganti Murphy; Csaba Szabó
Journal:  Int J Mol Med       Date:  2007-06       Impact factor: 4.101

8.  Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.

Authors:  D J Back; F Sutcliffe; J F Tjia
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

9.  Effect of chloroquine and primaquine on antipyrine metabolism.

Authors:  D J Back; H S Purba; B K Park; S A Ward; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

10.  The squalene-2,3-epoxide cyclase as a model for the development of new drugs.

Authors:  L Cattel; M Ceruti; F Viola; L Delprino; G Balliano; A Duriatti; P Bouvier-Navé
Journal:  Lipids       Date:  1986-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.